Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 4 , Pages 387-400 , December 2009

How accurately do we measure blood glucose levels in intensive care unit (ICU) patients?

  • Hans Günther Wahl, Dr. med. Dr. rer. nat. Dipl. Chem (Priv. Doz)

      Affiliations

    • Medizinisches Labor Wahl, Paulmannshöher Str. 14, 58515 Lüdenscheid, Germany
    • University of Marburg, University Hospital Gießen and Marburg GmbH, Location Marburg, Department of Clinical Chemistry and Molecular Diagnostics, Baldingerstraße, 35043 Marburg, Germany
    • Corresponding Author InformationMedizinisches Labor Wahl, Paulmannshöher Str. 14, 58515 Lüdenscheid, Germany. Tel.: +49 2351 462621; Fax: +49 2351 462616.

References 

  1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. The New England Journal of Medicine. 2001;345:1359–1367
  2. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. The New England Journal of Medicine. 2006;354:449–461
  3. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in servere sepsis. The New England Journal of Medicine. 2008;358:125–139
  4. Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Critical Care Medicine. 2008;36:3190–3197
  5. De La Rosa GDC, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care. 2008;12:R120
  6. Devos P, Preiser J, Mélot C. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. [abstract] Intensive Care Medicine. 2007;33:S189
  7. American Diabetes Association . Standards of medical care in diabetes — 2008. Diabetes Care. 2008;31(Suppl. 1):S12–S54
  8. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocrine Practice. 2007;13(Suppl. 1):1–68
  9. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Critical Care Medicine. 2008;36:296–327
  10. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933–944
  11. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Canadian Medical Association Journal. 2009;180(8):821–827
  12. NICE-SUGAR Study Investigators . Intensive versus conventional glucose control in critically ill patients. The New England Journal Of Medicine. 2009;360:1283–1297
  13. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151–3159
  14. Kanji S, Singh A, Tierney M, et al. Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Medicine. 2004;30:804–810
  15. Hirshberg E, Lacroix J, Sward K, et al. Blood glucose control in critically ill adults and children. Chest. 2008;133(6):1328–1335
  16. Merz TM, Finfer S. Pro/con debate: is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients?. Critical Care. 2008;12(2):212
  17. Brunkhorst FM, Wahl HG. Blood glucose measurements in the critically ill: more than just a blood draw. Critical Care. 2006;10(6):178
  18. Mahoney J, Ellison J. Assessing the quality of glucose monitor studies: a critical evaluation of published reports. Clinical Chemistry. 2007;53:1122–1128
  19. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurements: confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30:403–409
  20. Scott MG, Bruns DE, Boyd JC, et al. Tight glucose control in the intensive care unit: are glucose meters up to the task?. Clinical Chemistry. 2009;55:18–20
  21. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clinical Chemistry. 2001;47:209–214
  22. Price C. Point-of-care testing in diabetes mellitus. Clinical chemistry and laboratory medicine. 2003;41:1213–1219
  23. Wahl HG, Koschinsky T, Schlebusch H. Glukosebestimmung. In:  Luppa PB,  Schlebusch H editor. POCT - Patientennahe Labordiagnostik. 1st edn.. Berlin Heidelberg: Springer; 2008;p. 55–66
  24. Hannestad U, Lundblad A. Accurate and precise isotope dilution mass spectrometry method for determining glucose in whole blood. Clinical Chemistry. 1997;43:794–800
  25. Wiener K. Whole blood glucose: what are we actually measuring?. Annals of Clinical Biochemistry. 1995;32:1–8
  26. Burnett RW, D'Orazio P, Fogh-Andersen N, et al. Scientific Division, Working Group on Selective Electrodes: IFCC recommendation on reporting results for blood glucose. Clinica Chimica Acta. 2001;307:205–209
  27. Jørgensen LG, Brandslund I, Petersen PH, et al. The effect of the new ADA and WHO guidelines on the number of diagnosed cases of diabetes mellitus. Clinical Chemistry and Laboratory Medicine. 2003;41(9):1246–1250
  28. Bürgi W. The volume displacement effect in quantitative analyses in red cell constituents. Zeitschrift Für Klinische Chemie Und Klinische Biochemie. 1969;7:458–460
  29. D'Orazio P, Burnett RW, Fogh-Andersen N, et al. The International Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care Testing: approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clinical Chemistry. 2005;51:1573–1576
  30. Rainey PM, Jatlow P. Monitoring blood glucose meters. American Journal of Clinical Pathology. 1995;103:125–126
  31. Fogh-Andersen N, Wimberley PD, Thode J, Siggard-Andersen O. Direct reading glucose electrodes detect the molality of glucose in plasma and whole blood. Clinica Chimica Acta. 1990;189:33–38
  32. Savoca R, Jaworek B, Huber AR. New “plasma referenced” POCT glucose monitoring systems—are they suitable for glucose monitoring and diagnosis of diabetes?. Clinica Chimica Acta. 2006;372(1–2):199–201
  33. Lacara T, Domagtoy C, Lickliter D, et al. Comparison of point-of-care and laboratory glucose analysis in critically ill patients. American Journal of Critical Care. 2007;16(4):336–346
  34. Fogh-Andersen N, D'Orazio P. Proposal for standardizing direct- reading biosensors for blood glucose. Clinical Chemistry. 1998;44:655–659
  35. Steffes MW, Sacks DB. Measurement of circulating glucose concentrations: the time is now for consistency among methods and types of samples. Clinical Chemistry. 2005;51(9):1569–1570
  36. Tang Z, Lee JH, Louie RF, Kost GJ. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Archives of Pathology & Laboratory Medicine. 2000;124:1135–1140
  37. Wiener K. An assessment of the effect of haematocrit on the HemoCue blood glucose analyser. Annals Of Clinical Biochemistry. 1993;30:90–93
  38. Patrick L, Lynch M, O'Kane MJ. Methemoglobin interferes with the HemoCue B-Glucose Analyzer. Clinical Chemistry. 2002;48:581–583
  39. Tang Z, Louie RF, Payes M, et al. Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. Diabetes Technology & Therapeutics. 2000;2:349–362
  40. Kurahashi K, Maruta H, Usuda Y, Ohtsuka M. Influence of blood sample oxygen tension on blood glucose concentration measured using an enzyme-electrode method. Critical Care Medicine. 1997;25:231–235
  41. Kost GJ, Vu HT, Inn M, et al. Multicenter study of whole-blood creatinine, total carbon dioxide content, and chemistry profiling for laboratory and point-of-care testing in critical care in the United States. Critical Care Medicine. 2000;28:2379–2389
  42. Tang Z, Du X, Loie RF, et al. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. American Journal Of Clinical Pathology. 2000;113:75–86
  43. Kost GJ, Nguyen TH, Tang Z. Wholeblood glucose and lactate: trilayer biosensors, drug interference, metabolism, and practice guidelines. Archives Of Pathology & Laboratory Medicine. 2000;124:1128–1134
  44. Janssen W, Harff G, Caers M, Schellekens A. Positive interference of icodextrin metabolites in some enzymatic glucose methods. Clinical Chemistry. 1998;44:2379–2380
  45. Ashworth L, Gibb I, Alberti KG. Hemo Cue: evaluation of a portable photometric system for determining glucose in whole blood. Clinical Chemistry. 1992;38:1479–1482
  46. Rao LV, Jakubiak F, Sidwell JS, et al. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clinica chimica acta. 2005;356(1–2):178–183
  47. Marks V. Blood glucose: its measurement and clinical importance. Clinica Chimica Acta. 1996;251:3–17
  48. Burrin JM, Alberti KG. What is blood glucose: can it be measured?. Diabetic Medicine. 1990;7:199–206
  49. Tang Z, Louie RF, Lee JH, et al. Oxygen effects on glucose meter measurements with glucose dehydrogenase- and oxidase-based test strips for point-of-care testing. Critical Care Medicine. 2001;29:1062–1070
  50. Tang Z, Du X, Louie RF, Kost GJ. Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing. Archives Pathology Laboratory Medicine. 2000;124:577–582
  51. Karon BS, Griesmann L, Scott R, et al. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technology & Therapeutics. 2008;10(2):111–120
  52. Bellini C, Serra G, Risso D, et al. Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit. Clinical Chemistry and Laboratory Medicine. 2007;45(11):1549–1554
  53. Sharief N, Hussein K. Comparison of two methods of measurement of whole blood glucose in the neonatal period. Acta Paediatrica. 1997;86(11):1246–1252
  54. Chan PC, Rozmanc M, Seiden-Long I, Kwan J. Evaluation of a point-of-care glucose meter for general use in complex tertiary care facilities. Clinical Biochemistry. 2009;42(10–11):1104–1112
  55. Slater-MacLean L, Cembrowski G, Chin D, et al. Accuracy of glycemic measurements in the critically ill. Diabetes Technology & Therapeutics. 2008;10:169–177
  56. Ghys T, Goedhuys W, Spincemaille K, et al. Plasma-equivalent glucose at the point-of-care: evaluation of Roche Accu-Chek Inform and Abbott Precision PCx glucose meters. Clinica Chimica Acta. 2007;386(1–2):63–68
  57. Karon BS, Gandhi GY, Nuttall GA, et al. Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery. American Journal Of Clinical Pathology. 2007;127(6):919–926
  58. Harrison JG. Accuracy of fingerstick glucose values in shock patients. American Journal of Critical Care. 1995;4:44–48
  59. Kulkarni A, Saxena M, Price G, et al. Analysis of blood glucose measurements using capillary and arterial blood samples in intensive care patients. Intensive Care Medicine. 2005;31:142–145
  60. Kuwa K, Nakayama T, Hoshino T, Tominaga M. Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clinica Chimica Acta. 2001;307:187–192
  61. Finkielmann JD, Oyen LJ, Afessa B. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest. 2005;127:1749–1751
  62. Cartier LJ, Leclerc P, Pouliot M, et al. Toxic levels of acetaminophen produce a major positive interference on Glucometer Elite and Accu-Chek Advantage glucose meters. Clinical Chemistry. 1998;44:893–894
  63. U.S. Food and Drug Administration . Important Safety Information on Interference With Blood Glucose Measurement Following Use of Parenteral Maltose/Parenteral Galactose/Oral Xylose-Containing Products. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm154213.htm2009;Checked July 14th
  64. Nobels F, Beckers F, Bailleul E, et al. Feasibility of a quality assurance programme of bedside blood glucose testing in a hospital setting: 7 years experience. Diabetic Medicine. 2004;21:1288–1291
  65. Kavasak PA, Zielinski N, Li D, et al. Challenges of implementing point-of-care testing (POCT) glucose meters in a pediatric acute care setting. Clinical Biochemistry. 2004;37:811–817
  66. Baum JM, Monhaut NM, Parker DR, Price CP. Improving the quality of self-monitoring blood glucose measurement: a study in reducing calibration errors. Diabetes Technology Therapeutics. 2006;8(3):347–357
  67. Boyd R, Leigh B, Stuart P. Capillary versus venous bedside blood glucose estimations. Emergency Medicine Journal. 2003;22:177–179
  68. Corstjens AM, Ligtenberg JJM, Van der horst ICC, et al. Accuracy and feasibility of point-of-care and continuous blood glucose analyzing in critically ill ICU patients. Critical Care. 2006;10:R135
  69. Yamashita K, Okabayashi T, Yokoyama T, et al. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiologica Scandinavica. 2009;53(1):66–71
  70. Yamashita K, Okabayashi T, Yokoyama T, et al. The accuracy of a continuous blood glucose monitor during surgery. Anesthesia and Analgesia. 2008;106(1):160–163
  71. Opitz D. Patientennahe Sofortdiagnostik und Glykolyseinhibition in der Blutglukoseanalytik. INAUGURAL-DISSERTATION zur Erlangung des Doktorgrades der gesamten Medizin dem Fachbereich Medizin der Philipps-Universität Marburg 2007. http://archiv.ub.uni-marburg.de/diss/z2007/0378/pdf/ddo.pdfGlykolyseChecked July 14th 2009
  72. Vesper HW, Archibold E, Myers GL. Assessment of trueness of glucose measurement instruments with different specimen matrices. Clinica Chimica Acta. 2005;358(1–2):68–74
  73. Arabadjief D, Nicholas JH. Assessing glucose meter accuracy. Current Medical Research and Opinion. 2006;22(11):2167–2174
  74. Khan AI, Vasquez Y, Gray J, et al. The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Archives of Pathology & Laboratory Medicine. 2006;130(10):1527–1532
  75. NCCLS . Point-of-care blood glucose testing in acute and chronic care facilities; approved guideline – second edition. NCCLS document C30–A2 NCCLS; 2002;
  76. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clinical Chemistry. 2003;49:7–18
  77. Wehmeier M, Arndt BT, Schumann G, Külpmann WR. Evaluation and quality assessment of glucose concentration measurement in blood by point-of-care testing devices. Clinical Chemistry Laboratory Medicine. 2006;44:888–893
  78. Chen ET, Nichols JH, Duh SH, Hortin G. Performance evaluation of blood glucose monitoring devices. Diabetes Technology & Therapeutics. 2003;5:749–768
  79. Mahoney JJ, Ellison JM. Assessing glucose monitor performance—a standardized approach. Diabetes Technology & Therapeutics. 2007;9(6):545–552
  80. Slingerland RJ, Miedema K. Evaluation of portable glucose meters. Problems and recommendations. Clinical Chemistry and Laboratory Medicine. 2003;41:1220–1223
  81. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clinic Proceedings. 2004;79:992–1000
  82. Goldberg PA, Siegel MD, Sherwin R, et al. Implementation of a safe and effective insulin infusion protocol in medical intensive care unit. Diabetes Care. 2004;27:461–467
  83. Volgelzang M, Ligtenberg JJ. Practical aspects of implementing tight glucose control in the ICU. Current Opinion in Clinical Nutrition and Metabolic Care. 2007;10:178–180
  84. Skyler JS. Continuous glucose monitoring: an overview of its development. Diabetes Technology & Therapeutics. 2009;11:S5
  85. Mastrototaro JJ. The MiniMed continuous glucose monitoring system. Diabetes Technology & Therapeutics. 2000;2:S13–S18
  86. Hovorka R. The future of continuous glucose monitoring: closed loop. Current Diabetes Reviews. 2008;4(3):269–279
  87. De Block C, Manuel-y-Keenoy B, Rogiers P, et al. Glucose control and use of continuous glucose monitoring in the intensive care unit: a critical review. Current Diabetes Reviews. 2008;4(3):234–244
  88. Battelino T, Bolinder J. Clinical use of real-time continuous glucose monitoring. Current Diabetes Reviews. 2008;4(3):218–222
  89. Wentholt IM, Hart AA, Hoekstra JB, DeVries JH. Evaluating clinical accuracy of continuous glucose monitoring devices: other methods. Current Diabetes Reviews. 2008;4(3):200–206
  90. Clarke WL, Anderson S, Kovatchev B. Evaluating clinical accuracy of continuous glucose monitoring systems: Continuous Glucose-Error Grid Analysis (CG-EGA). Current Diabetes Reviews. 2008;4(3):193–199
  91. Sparacino G, Facchinetti A, Maran A, Cobelli C. Continuous glucose monitoring time series and hypo/hyperglycemia prevention: requirements, methods, open problems. Current Diabetes Reviews. 2008;4(3):181–192
  92. Reach G, Choleau C. Continuous glucose monitoring: physiological and technological challenges. Current Diabetes Reviews. 2008;4(3):175–180
  93. Hirsch IB, Armstrong D, Bergenstal RM, et al. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technology & Therapeutics. 2008;10(4):232–244
  94. Lodwig V, Heinemann L. Glucose Monitoring Study Group: continuous glucose monitoring with glucose sensors: calibration and assessment criteria. Diabetes Technology & Therapeutics. 2003;5:572–586
  95. Diabetes Research in Children Network (DirecNet) Study Group . The Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System in children with Type 1 Diabetes. Diabetes Care. 2007;30:59–64
  96. Csoregi E, Schmidtke DW, Heller A. Design and optimization of a selective subcutaneously implantable glucose electrode based on ‘‘wired'’ glucose oxidase. Analytical Chemistry. 1995;67:1240–1244
  97. Albisser AM, Leibel BS, Ewart TG, et al. An artificial endocrine pancreas. Diabetes. 1974;23:389–396
  98. Fogt EJ, Dodd LM, Jenning EM, Clemens AH. Development and evaluation of a glucose analyzer for a glucose controlled insulin infusion system (Biostator). Clinical Chemistry. 1978;24:1366–1372
  99. Hiramatsu S, Sako Y, Mimura K, et al. Impaired feedback inhibition of insulin secretion by hyperinsulinemia in patients with insulinoma. Endocrine Journal. 1995;42:39–42

PII: S1521-6896(09)00067-6

doi: 10.1016/j.bpa.2009.09.003

Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 4 , Pages 387-400 , December 2009

Article Tools

* Image Usage & Resolution